Question 1

What was the tested purity of lot TA110626?

Accepted Answer

Lot TA110626 (Thymosin alpha-1) tested at 98.237% HPLC purity from Synthesis Peptides, based on 2 Certificates of Analysis indexed by Disclosed Labs.

Question 2

Which lab tested lot TA110626?

Accepted Answer

Lot TA110626 was tested by Kovera Labs based on COA data in the Disclosed Labs corpus.

Question 3

Does lot TA110626 appear on multiple vendors?

Accepted Answer

Yes — lot TA110626 appears across 2 vendors in the Disclosed Labs corpus, which may indicate a reseller relationship or a recycled COA. The HPLC purity range across these COAs is 98.24%–98.24%.

Question 4

Was lot TA110626 tested for endotoxin?

Accepted Answer

Yes — lot TA110626 has at least one COA reporting an endotoxin (LAL) result: PASS. Endotoxin testing (USP <85> / LAL) is a safety panel that matters for injectable compounds.

TA110626

Cross-vendor collision detected

Tests reported

Vendor	Peptide	Lab	Purity	Tests	Tested
Synthesis Peptides	Thymosin alpha-1	Kovera Labs	98.24%	MSLALUSP<71>HM	—	Detail →Source
Orbitrex Peptides	Thymosin alpha-1	Kovera Labs	98.24%	MSLAL